Hodgkin Lymphoma Current Events | Hodgkin Lymphoma News | 2
|
| Page
2 of
8 |
149 Results |
|
|
|
Sort By:
Page Views | Date |
Experimental drug lets B cells live and lymphoma cells die
An investigative drug deprived non-Hodgkin lymphoma cells of their ability to survive too long and multiply too fast, according to an early study published recently in the journal Experimental Hematology. view more (2009-09-22)
Two targeted therapies likely better than one in patients with aggressive lymphoma
When combined with a cocktail of chemotherapy drugs, two monoclonal antibodies, instead of one, appear to offer superior results in patients with diffuse large B-cell lymphoma, according to Mayo Clinic researchers working with the North Central Cancer Treatment Group (NCCTG). view more (2009-05-15)
Relaxation and hypnotherapy - successful treatments for lymphoma?
A long term study of patients diagnosed with Hodgkin's disease or non-Hodgkin's lymphoma has found that those who were given relaxation therapy and hypnotherapy as well as chemotherapy were more likely to survive than those receiving chemotherapy on its own. These are the results of a study by Professor Leslie Walker, of Hull University, and Dr... view more... (2001-03-26)
Fathering cancer
EMBARGOED UNTIL WEDNESDAY 19 JUNE 2002 19:00 BST UK CONTACT - Claire Bowles, New Scientist Press Office, London: Tel: +44(0)20 7331 2751 or email claire.bowles@rbi.co.uk Is the next generation paying the price for Sellafield after all? WORKING at the Sellafield nuclear plant in Cumbria may have been harmful after all. Children of men who had... view more... (2002-06-19)
Cell division find prompts overhaul of immune response modelling
Research at the Walter and Eliza Hall Institute into the mechanics of how two types of white blood cells grow and die is fundamentally changing the development of computer models that are used to predict how immune system cells respond to a pathogenic threat. view more (2009-07-21)
Antibiotic treats lymphoma of the eye
The common antibiotic doxycycline effectively treats a type of lymphoma associated with chlamydia infection. view more (2006-10-04)
Novel treatments show improvements in survival and response rates for leukemia and lymphoma
The use of dexamethasone early in the treatment of children with acute lymphoblastic leukemia, the most common type of childhood cancer, may help reduce the risk of relapse. view more (2008-12-08)
Do patients at risk for B-cell malignancy need antiviral treatment?
Some studies have shown that a relationship of hepatitis C (HCV) infection with type II mixed cryoglobulinemia exists. However the precise mechanism remains unclear. view more (2009-04-15)
Exercise is good medicine for lymphoma patients
A healthy dose of exercise is good medicine, even for lymphoma patients receiving chemotherapy, University of Alberta researchers have found. view more (2009-10-28)
Malaria and Epstein-Barr virus linked to pediatric cancer in Africa
Endemic Burkitt lymphoma is a form of cancer that accounts for up to 74% of malignant disorders in children in equatorial Africa. Malaria and Epstein-Barr virus (EBV) are known cofactors in its development, but to date, their relative contribution has not been well understood. view more (2007-06-08)
Antibiotics may not be enough to stop recurrent gastric lymphoma caused by Helicobacter pylori
Research led by Dr. Anne Mueller at Stanford University School of Medicine demonstrates that successful eradication of Helicobacter may not prevent future aggressive gastric lymphoma since resting B cells are left behind. view more (2005-08-25)
Every patient is unique: Individualized therapies for non-Hodgkin's lymphoma
Positron emission tomography (PET) could be an important tool for identifying non-Hodgkin's lymphoma patients who are likely to respond well to treatment with 90 ibritumomab tiuxetan (IT)-the first radioimmunotherapy treatment approved for use by the U.S. Food and Drug Administration, said researchers at SNM's 55th Annual Meeting. view more (2008-06-17)
VCU Massey Cancer Center Spearheads Novel Clinical Study for Lymphoma Patients
The Virginia Commonwealth University Massey Cancer Center recently opened a National Cancer Institute (NCI)-sponsored, phase II clinical study for certain sub-types of non-Hodgkin's lymphoma. view more (2008-09-03)
Women face high risk of developing breast cancer following radiotherapy for Hodgkin’s Disease
Women who have received radiotherapy for Hodgkin’s Disease have a three times higher relative risk of developing breast cancer than women from the general population, Professor Dietlind Wahner-Roedler told the 3rd European Breast Cancer Conference today (Saturday 23 March). If the women were younger than 30 when they received the treatment... view more... (2002-03-21)
Early Detection Of Coeliac Disease Essential To Prevent Excess Deaths (p 356)
Death rates for people who have the intestinal disorder coeliac disease are twice that of the general population, conclude authors of a prospective study in this week's issue of THE LANCET. Early disease diagnosis is essential to prevent additional mortality. Coeliac disease is a disorder in which the small intestine is abnormally sensitive to... view more... (2001-08-01)
Adding radioimmunotherapy to chemo may help patients with lymphoma
Patients treated for follicular lymphoma, a slow-growing type of non-Hodgkin's lymphoma, may benefit from chemotherapy followed by radioimmunotherapy, according to a University of Pittsburgh Medical Center (UPMC) study presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago and published as Abstract 8005 in... view more... (2007-06-04)
UNMC researchers help make diagnostic breakthrough with Burkitt lymphoma; study detailed in New England Journal of Medicine
An international research study involving the University of Nebraska Medical Center, the National Cancer Institute and 10 other institutions has successfully identified the gene expression signature for Burkitt lymphoma. view more (2006-06-12)
Sunlight reduces risk of lymph gland cancer
A new study from Karolinska Institutet and Uppsala University shows that, contrary to previous belief, sunlight reduces the chances of developing tumours in the lymphatic glands (malignant lymphoma). The study is to be published in the next number of The Journal of the National Cancer Institute. view more (2005-01-28)
Study shows that maintenance rituximab is useful for advanced indolent lymphoma
A new study has found for the first time that maintenance therapy with the novel antibody, rituximab (MR) following cyclophosphamide, vincristine and prednisone (CVP) therapy improves progression-free survival in patients with stage III-IV indolent lymphoma. view more (2009-03-11)
Cutaneous T-Cell Lymphoma On The Rise, VA/Brown Research Shows
Cutaneous T-cell lymphoma, a rare and mysterious cancer, is on the rise, according to the first nationwide study of the disease in a decade. view more (2007-07-17)
|
|
| Page
2 of
8 |
149 Results |
|
|
|
Sort By:
Page Views | Date |
|
